Skip to search formSkip to main contentSkip to account menu

Selank

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Parkinson’s disease (PD) is the second most common severe neurodegenerative disorder that is characterized by progressive… 
2017
2017
It was shown that the anxiolytic effect of Selank is comparable to that of classical benzodiazepine drugs and that the basis of… 
2013
2013
The effect of single and course administration of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) in the dose 200 microg/kg on the rat… 
2010
2010
The effect of selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), which is a synthetic derivative of the endogenous tetrapeptide tuftsin… 
2008
2008
The effects of Selank, the active component of which is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, which includes the… 
2007
2007
Antiulcer properties of a synthetic anxiolytic Selank and in vivo formed metabolites of this compound were studied on 3… 
2006
2006
Peptide anxiolytic selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) applied intraperitoneally in doses of 0.01, 0.1, 1.0, and 10.0 mg/kg to… 
2003
2003
The actions of the synthetic heptapeptide preparation Selank on learning and memory processes in rats with initially low levels… 
2001
2001
Dose-dependent effect of synthetic heptapeptides Semax (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on… 
2001
2001
Examination of patients with various forms of anxiety and phobic disorders (according to DSM-4 criteria) demonstrated a…